All press releases

MYndspan

MYndspan is on a mission to improve access to preventive and proactive brain health and is the first company in the world to bring non-invasive Magnetoencephalography (MEG) technology directly to the consumer. MEG is typically only accessible in research and specialist clinical settings and is the most advanced method of recording and evaluating the brain while it is actively functioning.

MYndspan's brain health assessment technology is informed by 35 years of research and over 300 peer-reviewed studies. Its goal is to become a standard preventive health measure for monitoring and improving cognitive function, enabling earlier detection of neurodegenerative conditions and functional abnormalities linked to trauma, stress, or mental health disorders such as depression and PTSD.

Contact

London
April 30, 2026

MYndspan Opens Its Analysis Pipeline to Clinicians, MEG Labs, and Individuals Worldwide

MYndspan, the first company to bring clinical-grade magnetoencephalography (MEG) brain scanning directly to consumers, today announced a new capability that allows clinicians, MEG labs, and individuals who hold their own scan data to securely upload existing resting-state MEG recordings and receive a personalised brain health report covering functional brain age, brainwave activity, and network connectivity measures.

The service extends MYndspan's analysis platform beyond its own scanning centres for the first time, making the company's validated pipeline available to anyone, anywhere, with access to a MEG recording.

Visit myndspan.com/upload to learn more and get started today.

MEG is the most accurate non-invasive method for directly measuring brain function, capturing neural activity with millisecond-level temporal precision and millimetre-level spatial resolution. For decades, access has been limited to specialist hospitals and research institutions, not because of limitations in the science, but because of infrastructure costs and a lack of standardised analysis. The result: a large and growing body of MEG data, collected from real people in real studies, sitting in institutional archives with no practical path to clinical or personal use.

MYndspan's upload capability is a direct response to that gap. Each recording submitted through the secure platform is processed and benchmarked against its normative database. The service is designed for individual scans and is not intended for cohort-level research processing.

"There are MEG labs around the world that have been collecting exceptional data for years, often with no practical way to turn it into something meaningful for the people scanned," said Caitlin Baltzer, Founder and CEO of MYndspan. "This is an invitation to the broader MEG community. If you have recordings, we have the infrastructure to analyse them. We want to work with every lab, every clinician, every researcher, and every individual who believes MEG deserves a larger role in brain health."

The announcement reflects growing momentum around MEG as a data source across neuroscience, digital health, BCI, and AI research. MYndspan's proprietary analysis draws on decades of scientific work, incorporating signal cleaning, source localisation, time-frequency analysis, and functional connectivity mapping across a range of neurological and psychiatric indications.

Clinicians, MEG labs, and individuals interested in submitting recordings can learn more and register at myndspan.com/upload.

MYndspan is on a mission to improve access to preventive and proactive brain health and is the first company in the world to bring non-invasive Magnetoencephalography (MEG) technology directly to the consumer. MEG is typically only accessible in research and specialist clinical settings and is the most advanced method of recording and evaluating the brain while it is actively functioning.

MYndspan's brain health assessment technology is informed by 35 years of research and over 300 peer-reviewed studies. Its goal is to become a standard preventive health measure for monitoring and improving cognitive function, enabling earlier detection of neurodegenerative conditions and functional abnormalities linked to trauma, stress, or mental health disorders such as depression and PTSD.

Contact